11/21
04:17 am
sngx
Cutaneous T-cell Lymphoma Market Landscape Report 2024: Comprehensive Insights About 25+ Companies and 30+ Pipeline Drugs [Yahoo! Finance]
Medium
Report
Cutaneous T-cell Lymphoma Market Landscape Report 2024: Comprehensive Insights About 25+ Companies and 30+ Pipeline Drugs [Yahoo! Finance]
11/19
07:36 am
sngx
Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma [Yahoo! Finance]
Low
Report
Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma [Yahoo! Finance]
11/19
07:30 am
sngx
Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
Low
Report
Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
11/15
07:41 am
sngx
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event [Yahoo! Finance]
Medium
Report
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event [Yahoo! Finance]
11/15
07:30 am
sngx
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
Low
Report
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
11/14
07:26 am
sngx
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease [Yahoo! Finance]
Low
Report
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease [Yahoo! Finance]
11/14
07:15 am
sngx
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
Low
Report
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
11/8
07:30 am
sngx
Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results
Low
Report
Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results
10/24
07:30 am
sngx
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
Low
Report
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
10/22
07:30 am
sngx
Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
Low
Report
Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin
10/16
07:30 am
sngx
Soligenix Invited to Present at Upcoming Investor Conferences
Low
Report
Soligenix Invited to Present at Upcoming Investor Conferences
10/7
07:30 am
sngx
HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
High
Report
HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
10/3
07:30 am
sngx
Soligenix Announces Partnership with Sterling Pharma Solutions
Low
Report
Soligenix Announces Partnership with Sterling Pharma Solutions
9/16
07:30 am
sngx
Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024
Neutral
Report
Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024
9/3
07:30 am
sngx
Soligenix Receives European Patent for Improved Production of Synthetic Hypericin
Low
Report
Soligenix Receives European Patent for Improved Production of Synthetic Hypericin